Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ethinylestradiol/levonorgestrel monophasic - Bayer Schering Pharma

Drug Profile

Ethinylestradiol/levonorgestrel monophasic - Bayer Schering Pharma

Alternative Names: Levlite; Levonorgestrel/ethinylestradiol - Berlex; Microgynon 20; Microgynon 30; Microgynon Suave; Microlevlen ED; Microlite; Miranova

Latest Information Update: 05 Feb 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer Schering Pharma
  • Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pregnancy

Most Recent Events

  • 05 Feb 2019 Chemical structure information added
  • 11 Feb 2015 Launched for Contraception/Pregnancy (Prevention) in United Kingdom, Austria, Belgium, Greece, Israel, Netherlands, Poland, Singapore, Finland, Czech Republic, Russia, Spain, Norway, Thailand, Indonesia, Chile, Mexico, Malaysia and Hong Kong (PO) prior to February 2015
  • 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top